Roche agrees not to enforce patents in some developing nations
April 09 2004 11:00 PM ET
Pharmaceutical company Roche announced that it will not enforce existing patents on its anti-HIV medications in countries designated by the United Nations as "least developed," Dow Jones News reports. The company's drugs include the protease inhibitors Fortovase and Invirase. Roche also markets the fusion inhibitor Fuzeon with drugmaker Trimeris, and it's unclear whether that medication will be included in the company's patent nonenforcement plan. Additionally, Roche says it will no longer file patents on new antiretroviral drugs in the U.N.-designated countries and all of sub-Saharan Africa and will not take legal action against drugmakers in the region that manufacture cheap, generic versions of antiretrovirals patented elsewhere. The company made the decision to "underscore its belief that long-term success requires business to operate in ways that are not only economically but also socially and environmentally sustainable," according to a Roche press release.
- Holiday Guide: Shop Here, Not There
- Op-ed: Don't Worry, Tom Daley's Getting Biphobic Tweets, Too
- WATCH: Jared Leto on Avoiding Trans Character 'Cliché' for 'Dallas Buyers Club'
- Op-ed: Stop Judging Tom Daley and Dustin Lance Black
- Russia's High Court Declares 'Gay Propaganda' Ban Constitutional
- Op-ed: Straight Teen Girls Can Change the World
- Entertainment News James Franco Teases 50 Shades of Batman & Robin 29 min 57 sec ago
- Entertainment News Tom Daley: 'It Really Was Love at First Sight' 35 min 57 sec ago
- Sports WATCH: The Best From 6 Olympic Gay Divers 7:04 AM
- Commentary Op-ed: Stop Judging Tom Daley and Dustin Lance Black 6:00 AM
- Bisexual Op-ed: Don't Worry, Tom Daley's Getting Biphobic Tweets, Too 5:00 AM
- Women WATCH: Lesbian-Themed Web Series 'Kelsey' - Kelsey Gets All Kinds of Action December 04 2013 8:27 PM
- Travel Out Traveler Awards: Best Cruise Line? December 04 2013 7:42 PM